Amorçage Rhône Alpes
4
6M
3
0.25
2
- Stages of investment
- Areas of investment
Summary
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Medical, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Nanobiotix, Oslo Software, ERYtech Pharma.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Amoru00e7age Rhu00f4ne Alpes, startups are often financed by CapDecisif. The meaningful sponsors for the fund in investment in the same round are CapDecisif, Seventure Partners, Rhone-Alpes Creation. In the next rounds fund is usually obtained by Auriga Partners, European Investment Bank (EIB), Script Capital.
The fund is constantly included in less than 2 investment rounds annually. The higher amount of exits for fund were in 2017. This Amoru00e7age Rhu00f4ne Alpes works on 21 percentage points more the average amount of lead investments comparing to the other organizations. The usual things for fund are deals in the range of 5 - 10 millions dollars. The important activity for fund was in 2006.
Investments analytics
Analytics
- Total investments
- 4
- Lead investments
- 0
- Exits
- 2
- Follow on index
- 0.25
- Investments by industry
- Biotechnology (3)
- Biopharma (2)
- Medical (2)
- Software (1)
- Computer (1) Show 2 more
- Investments by region
-
- France (4)
- Peak activity year
- 2006
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 19
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Nanobiotix | 05 May 2010 | Biotechnology, Health Care, Therapeutics | Late Stage Venture | 8M | Ile-de-France, Paris, France |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.